Child Acute Malnutrition
Conditions
Keywords
child acute malnutrition, prevention, behavior change communication, lipid-based nutrient supplement, screening coverage
Brief summary
Globally, child undernutrition is the underlying cause for 3.1 million deaths of children younger than 5 years. 18.7 million children under five years of age suffer from severe acute malnutrition (SAM) and an additional 33 million children suffer from moderate acute malnutrition, and are at risk of developing SAM In Sub-Saharan Africa, there is often poor integration between programs to treat child acute malnutrition and programs that focus on the prevention of acute and chronic undernutrition - resulting in many missed opportunities for using prevention platforms to screen and refer SAM children, or for using screening and referral platforms to provide prevention services. This project will address two critical gaps related to the integration of preventive and treatment programs: 1) screening and treatment of MAM/SAM have not yet been systematically integrated into routine health-center visits or mainstreamed into community outreach programs; and 2) screening programs often do not offer any preventive services for those children found not to be suffering from MAM/SAM at the time of screening; mothers of children identified as non-MAM/SAM case are usually sent home without receiving any health or nutrition inputs and as a result, may fail to come back for screening because they do not see any tangible benefit associated with their participation in the screening. This project will specifically address these gaps by assessing the effect of an integrated approach consisting of higher screening coverage and preventive Behavior Change Communication (BCC) + Small-Quantity Lipid-based Nutrient supplementation (SQ-LNS) on both prevention and treatment of child undernutrition.
Detailed description
Because of the intended dual role of BCC/SQ-LNS on child undernutrition in this study - e.g. to help prevent child undernutrition and enhance the coverage of screening, referral and treatment of SAM/MAM, it is necessary to combine two study designs to rigorously evaluate the impact of the proposed intervention and to tease out the contribution of prevention and enhanced coverage/treatment to the overall impact on child malnutrition. The proposed study will therefore use two types of study designs. The first one is a repeated cross-sectional design that will compare select study outcomes between intervention and control groups at endline, after 24 months of program implementation. A repeated cross-sectional study design among children 0-17 months, at baseline and at study endline (on different children) will be used to assess the impact of the intervention on the prevalence of several outcomes, including the prevalence of MAM/SAM and stunting, the coverage of MAM/SAM screening and maternal ENA/IYCF/WASH knowledge and practices. The second proposed study design entails a longitudinal design whereby individual children will be recruited at birth and followed-up monthly until they reach 18 months of age. We anticipate needing approximately 5 months to recruit the required number of children (estimated at 2,040- 1,020 in the control group and 1,020 in the intervention group). This design will allow us to assess the intervention's effects on the incidence, recovery and recurrence rates of MAM/SAM.
Interventions
DIETARY_SUPPLEMENTLNS
A monthly dose of LNS (31 sachets of 20g) will be distributed to mothers attending well-baby visits and participating in small group counseling
BEHAVIORALChild's health and nutrition topics
After the well-baby visit. Caregivers will be invited to participate in a small group counseling or BCC (2-3 caregivers at a time). Every month a set of topics related to child's health and nutrition will be treated. These BCC sessions will be organized in an interactive way centering around the condition of the participating children.
BEHAVIORALNational policy well-baby visits
Sponsors
Helen Keller International
International Food Policy Research Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
No minimum to 17 Months
Healthy volunteers
Yes
Inclusion criteria
Cross-sectional study (baseline and endline) (n=2,310) Inclusion Criteria: * At least one index child 0-17 months of age in the household * Mother should be living in the study area since the index child's delivery * Singleton infants
Exclusion criteria
\- Index child should not present congenital deformations that hamper anthropometric measurements Longitudinal study (n=2,180) Inclusion Criteria: * child 0-1.4 months of age; * Mother should be living in the study area since the index child's delivery * Singleton infants
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of acute child malnutrition defined by WHZ<-2 or MUAC <125mm or bilateral pitting edema in children 0-17 months of age | After 24 months of program implementation | * Cross-sectional study * To calculate WHZ scores the 2006 WHO growth reference will be used * The MUAC criterion (125mm) is only used for children 6-17months of age |
| Screening coverage of acute child malnutrition (proportion of children monthly screened / total number of eligible children (aged 0-17 months) | monthly from study inclusion at 0 months to 17 months of age and at study endline | * Cross-sectional study * Longitudinal study |
| Incidence of child acute malnutrition defined by WHZ<-2 or MUAC<125mm | monthly from study inclusion at 0 months to 17 months of age | * Longitudinal study * To calculate WHZ scores the 2006 WHO growth reference will be used |
| Compliance to treatment of acute malnutrition (% of cases that complete treatment over total admitted) | monthly from study inclusion at 0 months to 17 months of age and at study endline | * Cross-sectional study * Longitudinal study |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mean mid-upper arm circumference in children 0-17 months of age | After 24 months of program implementation | — |
| Mean hemoglobin concentration in children 3-17 months of age | After 24 months of program implementation | Hemocues will be used to measure Hb concentration |
| Prevalence of child anemia (Hb concentration<10g/dL) in children 3 - 17 months of age | After 24 months of program implementation | — |
| Prevalence of severe acute child malnutrition defined by a WHZ<-3 or bilateral pitting edema or a MUAC<115mm in children 0-17 months of age | After 24 months of program implementation | The MUAC criterion (115mm) is only used for children 6-17months of age |
| Prevalence of severe stunting defined by a HAZ<-3 in children 0-17 months of age | After 24 months of program implementation | To calculate HAZ scores the 2006 WHO growth reference will be used |
| Incidence of child stunting defined by HAZ<-2 in children from 0 to 17 months | monthly from inclusion at 0 months to 17 months of age | To calculate HAZ score the 2006 WHO growth reference will be used |
| Caregiver's knowledge and practices related to Infant and Young Child Feeding (IYCF), Essential Nutrition Actions (ENA) and Water, Sanitation and Hygiene (WASH) | After 24 months of program implementation | — |
| Ponderal growth velocity (WHZ increment/month) | monthly from inclusion at 0 months to 17 months of age | To calculate WHZ score the 2006 WHO growth reference will be used |
| Weight gain (weight increment/month) | monthly from inclusion at 0 months to 17 months of age | — |
| Mid-upper arm circumference gain (MUAC increment/month) | monthly from inclusion at 0 months to 17 moths of age | — |
| Infant morbidity (acute respiratory infections, fever, malaria (RDT), vomiting, diarrhea) | monthly from inclusion at 0 months to 17 moths of age | Malaria will be tested in case of fever (or recalled fever over last 24hrs) use rapid tests |
| Relapse rate after treatment of MAM/SAM (proportion WHZ<-2 or MUAC<125mm or bilateral pitting edema after discharge from MAM or SAM treatment program over total number of children treated) | monthly from inclusion at 0 months to 17 months of age | — |
| Linear growth velocity (HAZ increment/month) | monthly from inclusion at 0 months to 17 months of age | To calculate HAZ score the 2006 WHO growth reference will be used |
| Prevalence of child stunting defined by HAZ<-2 in children 0-17 months of age | After 24 months of program implementation | To calculate HAZ scores the 2006 WHO growth reference will be used |
| Mean WHZ-score in children 0 -17 months of age | After 24 months of program implementation | To calculate WHZ scores the 2006 WHO growth reference will be used |
| Mean HAZ-score in children 0-17 months of age | After 24 months of program implementation | To calculate HAZ scores the 2006 WHO growth reference will be used |
Countries
Burkina Faso
Outcome results
None listed